CASI   $0.2075  -74.06% Market Closed

CASI Pharmaceuticals, Inc.
Total Cash 12.73M
totalCashPerShare 0.941
EBITDA -23.08M
Total Debt 18.46M
quickRatio 2.136
currentRatio 3.881
Total Revenue 23.10M
debtToEquity 204.689
Revenue/Share 1.722
ROA -0.26598
ROE -0.85426
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth -0.595
grossMargins 0.56805
ebitdaMargins -0.99911004
operatingMargins -2.40111
profitMargins -1.1767501
enterpriseValue 86.31M
forwardPE
floatShares 5.95M
sharesOutstanding 15.46M
sharesShort 109.99K
sharesShortPriorMonth 161.68K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.48%
heldPercentInstitutions 0.24%
Short Ratio help_outline 3.98%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.667
Price To Book help_outline 8.94
earningsQuarterlyGrowth
netIncomeToCommon -27.20M
trailingEps -2.03%
forwardEps -2.13%
enterpriseToEbitda -3.74
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2024
institutionsCount 26
lastUpdated Nov. 6, 2024, 5:23 p.m.